Spero Therapeutics (SPRO) Research & Development (2016 - 2025)
Historic Research & Development for Spero Therapeutics (SPRO) over the last 10 years, with Q3 2025 value amounting to $8.6 million.
- Spero Therapeutics' Research & Development fell 6799.81% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.7 million, marking a year-over-year decrease of 2695.02%. This contributed to the annual value of $96.8 million for FY2024, which is 8809.68% up from last year.
- As of Q3 2025, Spero Therapeutics' Research & Development stood at $8.6 million, which was down 6799.81% from $10.7 million recorded in Q2 2025.
- Spero Therapeutics' 5-year Research & Development high stood at $28.8 million for Q4 2024, and its period low was $7.4 million during Q3 2022.
- Its 5-year average for Research & Development is $15.4 million, with a median of $15.1 million in 2022.
- In the last 5 years, Spero Therapeutics' Research & Development surged by 14947.42% in 2024 and then plummeted by 6799.81% in 2025.
- Over the past 5 years, Spero Therapeutics' Research & Development (Quarter) stood at $17.2 million in 2021, then decreased by 12.4% to $15.1 million in 2022, then rose by 9.73% to $16.6 million in 2023, then skyrocketed by 74.16% to $28.8 million in 2024, then tumbled by 70.19% to $8.6 million in 2025.
- Its Research & Development was $8.6 million in Q3 2025, compared to $10.7 million in Q2 2025 and $13.6 million in Q1 2025.